We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
+10.65%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$63.8B
AUM Growth
+$3.93B
Cap. Flow
-$1.01B
Cap. Flow %
-1.58%
Top 10 Hldgs %
22.75%
Holding
3,125
New
60
Increased
388
Reduced
2,521
Closed
139

Sector Composition

Rank Sector Weight
1 Technology 24.2%
2 Healthcare 13.87%
3 Financials 12.55%
4 Consumer Discretionary 11.87%
5 Communication Services 9.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FSTR icon
2676
Foster
FSTR
$432M
$202K ﹤0.01%
15,028
-2,134
-12% -$29.6K
LCNB icon
2677
LCNB Corp
LCNB
$283M
$202K ﹤0.01%
14,765
-4,120
-22% -$58.6K
OSG
2678
DELISTED
Overseas Shipholding Group Inc.
OSG
$202K ﹤0.01%
94,576
-15,036
-14% -$32.7K
STXB
2679
DELISTED
Spirit of Texas Bancshares, Inc. Common Stock
STXB
$202K ﹤0.01%
18,130
-2,894
-14% -$34.1K
BRT
2680
BRT Apartments
BRT
$271M
$201K ﹤0.01%
17,040
-2,263
-12% -$26.3K
HMC icon
2681
Honda
HMC
$41.3B
$201K ﹤0.01%
+8,498
New +$215K
TAK icon
2682
Takeda Pharmaceutical
TAK
$55.7B
$201K ﹤0.01%
+11,266
New +$205K
EIGR
2683
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
$201K ﹤0.01%
821
-94
-10% -$29.2K
PWOD
2684
DELISTED
Penns Woods Bancorp
PWOD
$200K ﹤0.01%
10,071
-1,468
-13% -$30.6K
AMAL icon
2685
Amalgamated Financial
AMAL
$1.49B
$199K ﹤0.01%
18,783
-2,777
-13% -$32.4K
AQN icon
2686
Algonquin Power & Utilities
AQN
$4.42B
$198K ﹤0.01%
13,596
KALV
2687
DELISTED
KalVista Pharmaceuticals
KALV
$198K ﹤0.01%
15,753
-1,897
-11% -$23.7K
NBN icon
2688
Northeast Bank
NBN
$1.14B
$198K ﹤0.01%
10,787
-1,579
-13% -$28.1K
TSBK icon
2689
Timberland Bancorp
TSBK
$351M
$198K ﹤0.01%
11,006
-1,576
-13% -$27.2K
HMTV
2690
DELISTED
Hemisphere Media Group, Inc.
HMTV
$198K ﹤0.01%
22,839
-5,747
-20% -$51.5K
IMMR icon
2691
Immersion
IMMR
$252M
$196K ﹤0.01%
27,807
-6,203
-18% -$46.7K
PCYO icon
2692
Pure Cycle
PCYO
$261M
$196K ﹤0.01%
21,748
-3,365
-13% -$31.7K
LTRPA
2693
DELISTED
Liberty TripAdvisor Holdings, Inc. Series A
LTRPA
$195K ﹤0.01%
112,472
-15,510
-12% -$37.4K
AGRX
2694
DELISTED
Agile Therapeutics
AGRX
$195K ﹤0.01%
32
-5
-14% -$28.7K
ODT
2695
DELISTED
Odonate Therapeutics, Inc. Common Stock
ODT
$194K ﹤0.01%
14,446
-1,538
-10% -$43.6K
CMCL icon
2696
Caledonia Mining Corp
CMCL
$420M
$193K ﹤0.01%
11,350
-160
-1% -$3.18K
KIN
2697
DELISTED
Kindred Biosciences, Inc.
KIN
$193K ﹤0.01%
45,012
-5,350
-11% -$22.4K
KDNY
2698
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
$192K ﹤0.01%
15,799
-3,186
-17% -$42.7K
AVXL icon
2699
Anavex Life Sciences
AVXL
$310M
$190K ﹤0.01%
41,702
-8,810
-17% -$37.9K
CARE icon
2700
Carter Bankshares
CARE
$731M
$190K ﹤0.01%
28,556
-4,797
-14% -$34.2K

Similar funds

RhumbLine Advisers's Q3 2020 Portfolio in Review

As of Q3 2020, RhumbLine Advisers held 3,125 positions worth $63.8B, up 6.6% from $59.9B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

RhumbLine Advisers's Q3 2020 filing shows 60 new, 388 increased, 2,521 reduced and 139 closed positions. Its largest new stake was PROG Holdings: 245,531 shares worth $11.8M. The largest sale was Apple, an estimated $59.2M.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Healthcare and Financials.

  • RhumbLine Advisers's largest Q3 2020 buy was PROG Holdings: 245,531 shares worth $11.8M.
  • RhumbLine Advisers added most to Match Group in Q3 2020, an estimated $20M increase.
  • RhumbLine Advisers's biggest Q3 2020 reduction was Apple, cutting an estimated $59.2M.
  • RhumbLine Advisers fully exited Caesars Entertainment Corporation in Q3 2020, selling an estimated $19.1M.
  • RhumbLine Advisers's ten largest holdings make up 23% of its $63.8B portfolio in Q3 2020.
  • RhumbLine Advisers opened 60 new positions and closed 139 in Q3 2020.
  • RhumbLine Advisers's portfolio value rose 6.6% quarter-over-quarter to $63.8B.

Based on RhumbLine Advisers's 13F filing for Q3 2020, filed 12 Nov 2020.